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The population of Salmonella enterica serovar Typhi (S. Typhi), the causative agent of typhoid
fever, exhibits limited DNA sequence variation, which complicates efforts to rationally
discriminate individual isolates. Here we utilize data from whole-genome sequences (WGS)
of nearly 2,000 isolates sourced from over 60 countries to generate a robust genotyping
scheme that is phylogenetically informative and compatible with a range of assays.
These data show that, with the exception of the rapidly disseminating H58 subclade
(now designated genotype 4.3.1), the global S. Typhi population is highly structured and
includes dozens of subclades that display geographical restriction. The genotyping approach
presented here can be used to interrogate local S. Typhi populations and help identify recent
introductions of S. Typhi into new or previously endemic locations, providing information on
their likely geographical source. This approach can be used to classify clinical isolates and
provides a universal framework for further experimental investigations.
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T
yphoid fever (typhoid), caused by Salmonella enterica
serovar Typhi (S. Typhi) bacteria, is a systemic human
infection that affects an estimated 20.6 million people
globally each year, causing an estimated 223,000 deaths1–3.
Typhoid remains endemic in populations with limited access to
sanitation and safe water, and is a notiﬁable or reportable
infection in many industrialized countries, where it is generally
associated with travel to endemic areas. Public health laboratories
have relied on techniques such as phage typing4,5 or pulsed-ﬁeld
gel electrophoresis6, which are phylogenetically naive and have
limited discriminatory power to support epidemiological
investigations and surveillance.
A genotyping scheme based on 88 single-nucleotide poly-
morphisms (SNPs) identiﬁed within a limited set of genes was
previously developed for S. Typhi7. This enabled the classiﬁcation
of the S. Typhi population into 85 haplotypes (haploid genotypes)
based on biallelic proﬁles and provided the ﬁrst phylogenetic
framework for epidemiological studies8. Subsequently, whole-
genome sequencing (WGS) has been used to identify many
more SNPs and other phylogenetically informative markers
for discriminating within S. Typhi, which has limited genetic
variation9–16. Similar progress has been made in other
monophyletic clades of bacterial pathogens, such as
Mycobacterium tuberculosis17 and Yersinia pestis18.
We have recently reported the WGS of almost 2,000 S. Typhi
isolates sourced from 63 countries14. This study identiﬁed
422,000 chromosomal SNPs in the core genome, which were
used to build a comprehensive phylogenetic tree. Notably, the
analysis conﬁrmed the emerging dominance of the multidrug
resistance-associated H58 clade, including the recent spread of
H58 S. Typhi into Africa, conﬁrming the value of SNP-based
WGS analysis of S. Typhi to understand contemporary typhoid
epidemiology. Here we utilize these WGS data to deﬁne a global
population framework for S. Typhi and to deﬁne a new
genotyping scheme comprising 68 SNPs that provides
extensive coverage of typhoid-causing bacteria circulating
globally. Given the increasingly widespread adoption of WGS
by public health laboratories for the tracking of bacterial
pathogens19,20, we further aimed to explore the utility of S.
Typhi WGS data, analysed via genotyping, to predict the
geographical source of travel-associated S. Typhi isolated in the
United Kingdom. This approach gives greater discriminatory
power and improved phylogenetic information than the earlier
scheme7, and forms a robust framework for public health
surveillance, epidemiological investigations and laboratory
experiments of typhoid.
Results
Deﬁning phylogenetically informative genotypes for S. Typhi.
In order to develop a comprehensive genotyping system, we used
WGS data from 41,800 globally representative S. Typhi14 to
identify phylogenetically informative clades and subclades based
on SNP architecture21. A summary of the isolates is shown in
Table 1 and full details are provided in Supplementary Data 1 and
Supplementary Table 1. Using a combination of phylogenetic tree
topology and population genetic methods (using BAPS; Bayesian
Analysis of Population Structure21), we deﬁned 16 S. Typhi clades
that could be further divided into 49 subclades (Fig. 1, see
Methods). Most of the clades could be grouped into four nested
clusters (1–4, which we refer to as ‘primary clusters’), each with
100% bootstrap support and deﬁned by 420 SNPs (coloured
branches in Fig. 1a). The median pairwise distances between
isolates were as follows: 25 SNPs within subclades, 109 SNPs
within clades and 243 SNPs between clades. We labelled these
primary clusters, clades and subclades using a structured
hierarchical nomenclature system similar to that used for
M. tuberculosis17, whereby cluster 1 is subdivided into clades
1.1 and 1.2; clade 1.1 is further subdivided into subclades 1.1.1,
1.1.2, 1.1.3 and so on (see Fig. 1b, Methods). An interactive
version of the global phylogeny, with strains labelled by genotype,
country of origin and year of isolation, is available at
http://microreact.org/project/styphi22.
Under the new genotype nomenclature, the globally
disseminated multidrug resistant clone commonly referred to as
H58 (which actually includes haplotype H58 and eight other
H58-derived haplotypes under the original Roumagnac et al.
scheme7), constitutes a single subclade (4.3.1). No other subclades
were identiﬁed within clade 4.3. The CT18 reference genome
(H1 in Roumagnac et al. scheme) belonged to subclade 3.2.1,
while the laboratory strain Ty2 and its attenuated mutant
BRD948 (H10 under the Roumagnac scheme) belonged to clade
4.1 (with no further differentiation to subclade level by BAPS).
The backbone of the minimum spanning tree of Roumagnac et al.
haplotypes was broadly consistent with the backbone structure
of the whole-genome phylogeny (Supplementary Fig. 1a).
However, mapping the Roumagnac haplotypes to the whole-
genome phylogeny showed that the older scheme provides highly
uneven resolution across the S. Typhi phylogeny (Supplementary
Fig. 1b), with a lack of resolution in some cases (11 Roumagnac
haplotypes span two or more distinct subclades each; for example,
H52 comprises clades 3.4, 3.5, 4.1 and 4.2) and excessive
resolution in others (24 subclades are further divided into two
or more haplotypes in the Roumagnac scheme).
A new SNP-based genotyping framework for S. Typhi. We
identiﬁed a minimum set of 68 SNPs that can be used to genotype
S. Typhi into the four primary clusters, 16 clades and 49 sub-
clades. For each of these groups, we identiﬁed all SNPs that were
unique to members of the group, and selected one such SNP to be
used for genotyping. We prioritized the inclusion of synonymous
intragenic SNPs (that is, located within a protein-coding
sequence, but with no change to the encoded amino acid), within
genes that showed evidence of genetic stability within the S. Typhi
population (that is, nucleotide diversity o1% and dN/dS o0.7
across the global data set, with no inactivating mutations
identiﬁed). Details of the genotyping SNPs are given in
Supplementary Table 2. This genotyping scheme has greater
discriminatory power than the original Roumagnac haplotyping
scheme (D¼ 0.96 versus 0.78), is phylogenetically informative
by design and the hierarchical nomenclature of genotypes
is intrinsically informative with respect to phylogenetic relation-
ships between clades and subclades.
Geographical distribution of S. Typhi clades and subclades.
Next, we examined the geographical distribution of S. Typhi
genotypes. For these analyses, isolates of the same subclade,
country and year were collapsed to a single representative to
reduce the impact of localized outbreaks on our collection; this
resulted in 541 unique isolates for analysis. Primary clusters 2, 3
and 4 were broadly distributed across continents (greens, blues
and reds, respectively, in Fig. 1c), likely reﬂecting the relatively
ancient spread of S. Typhi across the globe. Isolates outside these
clusters, which result from deep branching closer to the root of
the S. Typhi whole-genome tree, were rare in our collection
(n¼ 24 unique isolates) and mostly found in Africa (n¼ 16).
While the three common clusters (2–4) were present in most
regions we analysed, cluster 2 predominated among American
isolates (n¼ 18/23 unique isolates, 78%). Most clades were
detected on multiple continents (n¼ 11/16) and included isolates
from Asia (n¼ 13/16) and/or Africa (n¼ 10/16), which together
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Table 1 | Summary of 1,831 S. Typhi.
Continent (region) Country of origin (nZ5) Range of isolation dates (years) Number of isolates
Asia 1972–2012 1068 (58.3%)
Southeast Asia 1976–2012 719
Cambodia 2007–2012 210
Indonesia 1976–2012 129
Laos 2000–2010 138
Vietnam 1972–2011 221
Malaysia 2005–2011 6
Other (Philippines, Thailand, East Timor, Myanmar) 2002–2012 15
South Asia 1977–2012 321
Bangladesh 1998–2012 51
India 1977–2012 174
Nepal 1999–2012 47
Pakistan 2003–2012 45
Other (Sri Lanka, Afghanistan) 2001–2012 4
Western Asia 1997–2011 25
Iraq 2006–2011 11
Lebanon 2001–2011 7
Other (Armenia, Palestine, Turkey, Western Asia) 1997–2011 7
Eastern Asia 2002–2011 3
Other (China) 2002–2011 3
Africa 1958–2013 374 (20.4%)
North Africa 1961–2009 24
Algeria 1999–2009 7
Morocco 1999–2000 9
Other (Sudan, Egypt, Tunisia) 1961–2008 8
East Africa 1980–2010 115
Kenya 1998–2009 56
Tanzania 2006–2010 52
Other (Comoros, Madagascar) 1980–2002 7
Central Africa 1958–2011 49
Cameroon 1958–2009 27
DRC 1976–2011 17
Other (Angola, Central African Republic) 2001–2009 5
West Africa 1998–2009 30
Other (Burkina Faso, Cape Verde, Benin, Guinea, Ivory Coast, Gabon,
Liberia, Mali, Niger, Nigeria, Mauritania, Senegal, Togo)
1998–2009 30
Southern Africa 2004–2013 153
Malawi 2004–2013 112
South Africa 2004–2012 41
Africa 2009–2012 3
Unknown 2009–2012 3
Europe 1916–2009 7 (0.4%)
Eastern Europe 1916–1996 2
Other (Russia) 1916–1996 2
Western Europe 2009 4
Other (France (suspected African origin of infection)) 2009 4
Southern Europe 2009 1
Other (Malta) 2009 1
Australia and Oceania 1980–2012 342 (18.7%)
Australia 2010–2012 3
Australia 2010–2012 3
Oceania 1980–2012 339
Fiji 1981–2012 170
Samoa 1992–2012 117
Papua New Guinea 1980–2012 47
Other (Tonga, Vanuatu) 1980–2003 5
North America 1958–2011 5 (0.3%)
Other (USA, Mexico) 1958–2011 5
Central America 2012 1 (0.05%)
Other (El Salvador) 2012 1
South America 1905–2012 17 (0.9%)
Argentina 1905–2006 10
Other (French Guiana, Peru, South America ) 2002–2012 6
Unknown origin 1939–2012 19 (1.0%)
S. Typhi, Salmonella enterica serovar Typhi.
Typhi isolates from the global collection, which were used to deﬁne genotypes. Countries with fewer than ﬁve isolates were grouped into the category ‘Other’; n indicates the number of such countries in
each region.
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Figure 1 | Population structure of S. Typhi based on genome-wide SNPs. (a) Whole-genome tree of 1,831 global S. Typhi isolates. Primary clusters 1–4 are
indicated in the outer coloured ring; branches deﬁning these groups are coloured in the tree. These groups are further divided into clades, which are shaded
and labelled. The location of S. Typhi reference genomes CT18 (accession number AL513382) and Ty2 (accession number AE014613) are indicated on the
tree. Subclade 4.3.1 (H58, marked in red), which comprises half of the global collection, is represented by just 50 (6%) randomly selected isolates out of
the total 852 belonging to this subclade, so that the relationships between other clades can be visualized. (b) Tree backbone showing further division of 16
S. Typhi clades (shaded) into 49 subclades (labelled; note 12 undifferentiated clade groups shown in brackets). Branches are coloured by primary cluster.
(c) Map of the world showing subclade diversity of S. Typhi isolates in the global collection, by region22. Where groups of isolates from the same country
and year belonged to the same subclade, this was classiﬁed as an ‘outbreak’ and the group is only represented once in the pie graphs. Pies are sized to
indicate number of isolates; slices are coloured by clade; multiple slices of the same colour indicate multiple subclades belonging to the same clade.
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made up 78% of our isolate collection (Table 1). However, there
were differences in the geographic distributions of clades, with
most clades being dominated by unique isolates from a single
continent (Asia, Africa or Oceania; see Supplementary Fig. 2).
In contrast, at the subclade level, only 22% of subclades
(n¼ 11) were found on more than one continent, and most were
dominated by unique isolates from a single country or region:
40 subclades (82%) had Z50% of non-outbreak isolates from a
single country (Fig. 2) and 44 subclades (90%) had Z50% of
non-outbreak isolates from a single region (Fig. 2). A total of 28
subclades comprised ﬁve or more non-outbreak isolates each, and
of these common subclades, 12 (43%) were detected in a single
region only (six in Oceania, ﬁve in Southeast Asia and one in
South Asia; Fig. 2). In total, 16 common subclades (57%) were
highly restricted to a region (490% of isolates drawn from a
single region) and 20 (71%) were generally associated with one
region (470% of isolates drawn from a single region; Fig. 2).
These data suggest that most S. Typhi subclades represent
localized bacterial subpopulations with barriers to geographical
dispersion, and that transfers to new locations rarely result in
long-term establishment of local populations. In contrast with
this general pattern, subclade 4.3.1 (previously H58) was found in
nine different regions across Africa, Asia and Oceania. Only 10
other subclades (20%) were found on more than one continent,
and the majority of these were dominated either by Asian,
African or Oceanian isolates (Fig. 2). Thus, the recent global
dissemination of subclade 4.3.1, which spread out of South Asia
B30 years ago and has established successful local clonal
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Figure 2 | Geographical clustering of S. Typhi subclades. Heatmap shows, for each subclade, the percentage of unique isolates originating from each of
the geographical regions. Where groups of isolates from the same country and year belonged to the same subclade, this was classiﬁed as an ‘outbreak’ and
the group is only represented once. The same data are represented as a scaled bar graph to the right. The full list of isolates by country and subclade is
provided in Supplementary Data 1.
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expansions in dozens of countries14, likely represents a
comparatively rare event in the evolutionary history of S. Typhi.
Genomic prediction of the geographical origins of S. Typhi by
comparison with the global framework. Since most S. Typhi
subclades were associated with a narrow geographical source, we
hypothesized that genotyping of S. Typhi isolates could be used to
predict the likely geographical origins of typhoid cases. As this is
clearly challenging for the more widely distributed subclades, we
also sought to examine whether speciﬁc SNPs could be used to
predict origins down to the country level. For 1,501 out of 1,831
(82%) isolates in our global collection, the genetically closest
isolate was from the same country. Where the closest isolate was
0–1 SNPs away, this frequency was 95% and foro10 SNPs, 90%
(Supplementary Fig. 3).
Since our current global genome collection includes groups of
isolates that were frequently collected from the same time and
place, this should not be taken as a reliable measure of the general
predictive power of SNP distance for S. Typhi. In order to further
explore the power of our global genomic framework to predict
geographic origins of travel-associated typhoid, we sequenced and
genotyped 99 novel S. Typhi that were isolated from patients
attending a hospital in East London, United Kingdom between
2005 and 2010 (Table 2). A total of 13 genotypes were identiﬁed.
Epidemiological interviews were able to link 81 of these cases with
travel to a speciﬁc country; the remaining 18 cases were not
associated with travel. The median SNP distance between
these novel isolates and genomes in our global collection was
21 SNPs (interquartile range, 18–25 SNPs), posing a challenge
for prediction of their geographical origin. Among the 81
travel-associated UK isolates, 53 were genotyped as 4.3.1; these
were all linked to travel to countries within South Asia (Table 3),
and clustered along with South Asian isolates from the global
collection (Fig. 3 and Supplementary Fig. 4n). For the 28
non-4.3.1 travel-associated UK isolates, the location of travel
generally matched the geographical origin of the closest isolate
(in terms of number of SNPs) in the global collection: travel
location and closest global isolate source matched at the region
level in all cases, and at the country level in most cases (n¼ 20,
71%). That is, prediction of geographical origin based on the
Table 2 | Summary of 99 East London travel-associated
S. Typhi isolates used in the study.
Country of origin Range of isolation
dates (year)
Number of
isolates
Bangladesh 2006–2012 38
India 2006–2012 22
Pakistan 2006–2012 13
Nepal 2007 1
India/Pakistan* 2008 1
India/Kuwait* 2008 2
Bangladesh/India* 2010 2
Nigeria 2009 1
Ghana 2007 1
No known travel 2005–2011 18
Total 2005–2012 99
S. Typhi, Salmonella enterica serovar Typhi.
The country of origin and range of isolation dates (years) for the isolates are described.
*For ﬁve patients, multiple countries of travel were recorded, and it was not possible to conﬁrm
in which country the S. Typhi infection originated.
Table 3 | Summary of genotyping and SNP results for travel-associated S. Typhi isolates with known country of travel.
Subclade Country of travel N
(travel)
Closest genome country
match
N
(global)
Region frequencies (excluding
outbreaks)
2.0.1 Bangladesh 1 1 9 *South Asia (100%)
2.1.7 India 2 2 49 Oceania (92%)
2.2.0 Pakistan 1 1 17 Southern Africa (24%)
East Africa (24%)
South Asia (18%)
2.2.2 India 1 1 9 South Asia (33%)
Western Asia (33%)
2.3.3 Bangladesh 2 2 9 South America (56%)
South Asia (33%)
3.1.1 Nigeria, Ghana 2 0 25 *West Africa (68%)
3.2.2 Bangladesh, Pakistan 3 2 12 *South Asia (83%)
3.3.0 Bangladesh, Pakistan, India 14 13 30 *South Asia (83%)
3.3.1 Pakistan 1 1 32 East Africa (44%)
South Asia (19%)
4.1.0 India 1 1 78 Southeast Asia (71%)
4.3.1 Bangladesh, India, Pakistan, Nepal,
Kuwait
53 — 853 Southeast Asia (50%)
South Asia (26%)
Closest genome country match, number of travel-associated isolates whose country of travel matched that of the closest genome in the global collection (based on lowest number of SNPs); N (global),
number of isolates in the global collection that were assigned to this subclade; N (travel), number of travel-associated isolates that were assigned to the subclade; Region frequencies, frequency of each
geographic region among isolates of this subclade from the global collection (note groups of isolates from the same subclade, country and year were classiﬁed as outbreaks and represented only once per
group in the frequency calculations); SNP, single-nucleotide polymorphism; S. Typhi, Salmonella enterica serovar Typhi.
*Highlights the most frequent region for this subclade among the global collection, where this matches the region of travel.
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closest strain of known location in the current global framework
would have yielded the correct region of origin in all cases, and
the correct country of origin in 71% of cases (95% conﬁdence
interval (CI), 66–76%). Furthermore, for non-4.3.1 subclades,
genotyping alone was predictive of geographical origin at the
regional level for the same proportion of isolates (71%).
It is likely that power to predict the geographical sources of UK
isolates would be improved by wider geographical coverage in the
reference genome collection. Two of these isolates were
genotyped as subclade 3.1.1 and linked with travel to Ghana
and Nigeria; the closest isolates in our global collection were
16–17 SNPs away and were not from these precise locations,
but likely originated from bordering countries in West Africa
(Supplementary Fig. 4e). It is likely that a deeper coverage of West
African isolates in our global framework would provide greater
power to resolve geographic associations within this region,
which comprised less than 2% of our current global collection
(n¼ 30 isolates). Similarly, for the other travel-associated isolates
for which the recorded country of travel did not match the closest
genome in the global tree, the closest genome was also from a
neighbouring country (for example, Pakistan, India, Bangladesh;
see Supplementary Fig. 4).
Genomic predictions of the geographical origins of 18
non-travel-associated UK isolates are shown in Table 4 and
Supplementary Fig. 4. Thirteen isolates were 4.3.1 and clustered
together with travel-associated isolates from South Asia, within a
broader group of South Asian 4.3.1 isolates (Fig. 3). This suggests
that S. Typhi imported into the United Kingdom from these
regions have likely been transmitted onwards within the
United Kingdom to individuals with no recent travel history
(Supplementary Fig. 4n). Two additional isolates were from
subclades that were dominated by a single region in our global
collection—3.1.1 (68% West Africa) and 3.3.0 (83% South Asia).
Notably, while the 4.3.1 isolates were closely related to travel-
associated isolates recently obtained in London, they were Z17
SNPs away from any isolates in the global collection. Thus, the
diversity captured by the global collection does not provide the
resolution to precisely identify the origin of these isolates23.
Discussion
Our data show that the global S. Typhi population consists of
49 distinct subclades that are strongly geographically clustered,
with many locations harbouring subpopulations of S. Typhi
established over long periods of time. We show how these
4.3.0
4.1.0
2.0.1
2.1.7
2.2.0
2.3.3
3.1.1
2.0.2
2.2.2
3.0.1
3.2.23.3.03.3.1
Figure 3 | Phylogeny of 99 travel-associated S. Typhi in comparison with the global genomic framework containing 1,831 isolates.Whole-genome SNP
tree is shown in the centre and branches are coloured by clade. Rings indicate region of origin: inner ring, global collection; outer ring, travel-associated
isolates. Subclades that contain travel-associated isolates are highlighted within the tree (shaded in alternating colours) and labelled around the outside;
intrasubclade phylogenies are provided in Supplementary Fig. 4.
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subclades can be identiﬁed through a simple genotyping scheme
consisting of 68 SNPs. Importantly, while we show that this
scheme is highly phylogenetically informative, it can be readily
inferred from raw sequence data without the need for multiple
genome comparisons, phylogenetic analysis or any other complex
or computationally intensive steps. Such properties make this
universal SNP-based system a valuable tool upon which
researchers can develop future studies. The S. Typhi genome is
highly stable and exhibits minimal genetic variation and virtually
no recombination9,14, and we recently estimated the substitution
rate to be slower than one SNP per genome per year14; therefore,
the genotyping framework is expected to be robust to future
evolution.
Owing to the strong geographical clustering of the various
subclades, whole-genome comparison of novel S. Typhi isolates to
the existing global population framework is strongly predictive of
geographic origin at the regional level and has the potential to
accurately predict origins to the country level. This has important
public health implications for typhoid surveillance and control in
endemic and non-endemic areas; however, ongoing updates to
the global genomic framework will be important to ensure the
utility of genomic surveillance for typhoid. For example, we found
that the origin of travel-associated 4.3.1 isolates could not be
resolved using the prior global framework alone, but beneﬁtted
from updated information provided by other recent travel-
associated isolates of known geographical origin. This illustrates
the importance of expanding and updating the global genomic
framework through sequencing of novel isolates and suggests
that, while ongoing surveillance in endemic areas is undoubtedly
important, the use of clinically well-characterized travel-asso-
ciated organisms isolated in non-endemic countries may also
provide a valuable source for improving the granularity of
data in the framework for genome-based surveillance of
S. Typhi23. In addition, it will be important to expand the
current global framework to include more recent isolates
(the most recent in our current collection was from 2013) as
well as isolates from regions that are currently under-represented
(including Africa, the Americas and northeast Asia).
WGS-equipped reference laboratories provide a highly
accessible source to expand the global genomic framework for
typhoid, with potential beneﬁts to local but also global typhoid
control. For example, in England, Wales and Northern Ireland
B520 typhoid cases are reported annually to the national
reference laboratory (Public Health England). These cases are
investigated in order to determine whether they are associated
with travel to typhoid endemic regions23. However,
approximately one-ﬁfth of typhoid cases in the United
Kingdom cannot be traced to a country of origin. At present,
Public Health England provides molecular typing, which since
April 2015 includes WGS as well as antimicrobial susceptibility
proﬁling, for S. Typhi isolated from such cases. The resulting data
are considered important for local epidemiology. However, we
propose that this could also serve as a proxy for informal
surveillance of typhoid molecular epidemiology in endemic
regions. This may prove particularly valuable when supported
by our genotyping framework for simpliﬁed attribution.
Methods
Bacterial isolates and WGS. A total of 1,930 S. Typhi isolates were analysed in
this study (Supplementary Data 1), including a collection of 1,831 globally
distributed isolates contributed by members of the International Typhoid
Consortium14 and 99 novel S. Typhi isolated in East London, UK. S. Typhi
comprising the global collection were isolated between 1905 and 2013 and originate
from 65 countries spanning six continents (Asia, Africa, North and South America,
Europe, and Australia and Oceania) as previously described14.
An additional 99 novel S. Typhi isolates were obtained from returning travellers
with a febrile illness who presented at The Royal London Hospital, Barts Health
NHS Trust in East London, UK, between 2005 and 2012. Travel history, available
for 81 of the travellers, included visits to seven countries within the continents of
Asia and Africa. DNA was extracted using the Wizard Genomic DNA Kit
(Promega, Madison, WI, USA) as per the manufacturer’s instructions.
Index-tagged paired end Illumina sequencing libraries were prepared as previously
described24. These were combined into pools, each containing 96 uniquely tagged
libraries, and were sequenced on the Illumina Hiseq2500 platform (Illumina, San
Table 4 | Summary of genotyping and SNP results for travel-associated S. Typhi isolates of unknown origin.
Isolate Country of closest SNP match Distance (#SNPs) Subclade Subclade distribution
H06434426 Mexico 146 2.0.2 North America (50%)
North Africa (50%)
H06156550 Pakistan 92 3.0.1 South Asia (50%)
North Africa (50%)
H05272442 Ghana 17 3.1.1 *West Africa (68%)
H09176223 Bangladesh 11 3.3.0 *South Asia (83%)
H10182335 India 18 3.3.1 East Africa (44%)
South Asia (19%)
H10046338 Bangladeshw 13 4.3.1 Southeast Asia (50%)
South Asia (26%)
H05406403 Bangladeshw 4
H06136379 Bangladeshw 19
H06136380 Bangladeshw 17
H05118260 Bangladesh/Indiaw 19
H10382491 Indiaw 9
H10394694 Indiaw 9
H06016481 Indiaw 9
H05196407 Indiaw 14
H05196408 Indiaw 12
H05212226 Indiaw 17
H11372598 Pakistanw 10
H09266336 Pakistanw 9
SNP, single-nucleotide polymorphism; S. Typhi, Salmonella enterica serovar Typhi.
For each London isolate, the closest isolate in the global collection was determined (closest¼ smallest SNP distance, that is, smallest number of core genome SNPs); the country and SNP distance are
recorded.
*Highlights the most frequent region for this subclade among the global collection, where this matches the region of the closest isolate in the global collection.
wLocation of closest travel-associated isolates from London (unresolvable beyond ‘South Asia’ based on the global collection alone).
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Diego, CA, USA) according to the manufacturer’s protocols to generate tagged 100
base pair (bp) paired-end reads.
SNP analysis. For analysis of SNPs, the paired-end reads were mapped to the
reference genome of S. Typhi CT18 (ref. 25), using SMALT (version 0.7.4; http://
www.sanger.ac.uk/resources/software/smalt/). SNPs were identiﬁed as previously
described14, using samtools mpileup26 and ﬁltering with a minimum mapping
quality of 30 and a quality ratio cutoff of 0.75 (ref. 24). SNPs located within phage
regions, repetitive sequences or recombinant regions were excluded as previously
described14, resulting in a ﬁnal set of 22,143 chromosomal SNPs in an alignment
length of 4,275,037 bp for the global collection of 1,831 S. Typhi isolates. An
expanded alignment comprising 22,673 SNPs from S. Typhi isolates from the
global collection (1,831) plus 99 traveller-associated UK isolates was generated
using the same procedures as above. Pairwise SNP distances between isolates (that
is, the number of core genome SNP loci at which pairs of isolates had discordant
alleles) were extracted from each alignment i using the ape package27 for R (v3.2;
function call: dist.dna(i,model¼ "N",pairwise.deletion¼T)).
Phylogenetic analyses. The maximum likelihood (ML) phylogenetic tree shown
in Fig. 1 was built from the 22,143-SNP alignment of all 1,831 isolates using
RAxML (version 7.8.6)28 with the generalized time-reversible model and a Gamma
distribution to model site-speciﬁc rate variation (the GTRþ g substitution model;
GTRGAMMA in RAxML). The tree was outgroup-rooted by including a pseudo-
sequence comprising S. Paratyphi A alleles in the alignment. Support for the ML
phylogeny was assessed via 100 bootstrap pseudo-analyses of the alignment data.
The backbone topology of the global ML tree, showing relationships between
subclades (Fig. 1b), was recovered by randomly selecting one isolate from each
subclade to retain, and removing all other tips from the tree (using drop.tips() in
the ape package27 for R (v3.2)). A ML phylogenetic tree was also generated
separately from 22,673 SNPs of S. Typhi isolates from the global collection (1,831)
plus the 99 East London traveller-associated isolates, using the same procedures
as above. All ML trees were visualized and annotated using Python
(https://github.com/katholt/plotTree/#python-code).
Identiﬁcation of phylogenetically informative clades and subclades. In
addition to the whole-genome phylogenetic analysis outlined above, we
investigated the population structure of the global S. Typhi collection using a
phylogeny-free population genetics approach, implemented in BAPS v.6.0 (ref. 21).
Hierarchal clustering analyses were conducted on identiﬁed clusters until single-
member clusters were obtained, thus allowing the discovery of nested genetic
population structures21. Ten nested levels of molecular variation were ﬁtted to the
data using 10 independent runs of the stochastic optimization algorithm with the a
priori upper bound of the number of clusters varying over the interval 50–300
across the runs30.
As our goal was to identify genotypes that were both phylogenetically and
epidemiologically informative, we explored the homogeneity (1-Simpson’s
diversity) of geographical source within BAPS clusters (as an indicator of the
potential power of genotyping to identify geographical origin of travel-associated
isolates) at different levels of clustering (Supplementary Fig. 5). This showed that
within-cluster homogeneity increased up to the sixth level of clustering and then
reached a plateau, with deeper clustering providing no greater resolution of
geographical origin (Supplementary Fig. 5). The third level of clustering resulted in
most clusters being dominated by a single continent (14/17 clusters with480% of
isolates from one continent), while sixth-level clustering resulted in most clusters
containing isolates from a single country (60/89 clusters with 480% of isolates
from one country; Supplementary Fig. 6). We therefore used the BAPS clusters to
guide the deﬁnition of clades (BAPS level 3) and subclades (BAPS level 6).
In order to maintain compatibility with the phylogeny, some minor
modiﬁcations of the raw BAPS clusters were required (this consisted of subdividing
some BAPS clusters and merging others, but not reassigning members between
clusters; see Supplementary Fig. 7). The modiﬁed level-3 BAPS clusters were
designated ‘clades’ and were assigned labels of the form [x].[y], where [x] indicates
to which major cluster each clade belongs and [y] designates sister clades within
each major cluster. The modiﬁed level-6 BAPS clusters were designated ‘subclades’
and assigned labels of the form [x].[y].[z], where [x].[y] indicate to which clade
each subclade belongs and [z] designates sister subclades within each clade. Thus,
genotype names indicate relationships between genotypes; for example, 2.1.1 and
2.1.2 are sister subclades within clade 2.1, while 2.2.1 is a member of the distinct
clade 2.2.
Some BAPS clusters were polyphyletic and consisted of isolates belonging to
rare phylogenetic lineages whose common ancestor in the phylogenetic tree
coincided with the common ancestor of an entire clade (n¼ 9) or primary cluster
(n¼ 2). These groups contain isolates that, given increased numbers, may emerge
as distinct BAPS clusters that form sister taxa within the parent clade (or primary
cluster), and were thus designated [z]¼ 0 (or [y]¼ 0) to indicate non-equivalence
with the properly differentiated sister clades (n¼ 16) or subclades (n¼ 49). For
example, while the genotypes 2.1 and 2.2 represent distinct sister clades that are
each monophyletic, isolates assigned to 2.0 are paraphyletic and include multiple
lineages that could not be further subdivided by BAPS analysis (Supplementary
Fig. 7).
Subclade 4.3.1, which is the only subclade of Clade 4.3, corresponds to the
group referred to as H58, based on the haplotyping scheme of Roumagnac et al. in
which it is deﬁned by the presence of a single SNP glpA-C1047T (position
2,348,902 in S. Typhi CT18, BiP33 (ref. 7)). BAPS clustering at any level could not
further subdivide subclade 4.3.1 (H58).
SNP-based genotyping. We identiﬁed a minimum set of 68 SNPs with which to
rapidly genotype S. Typhi into the 16 clades and 49 subclades, as described above
(Supplementary Table 2). Short read alignment (BAM) ﬁles, generated by mapping
Illumina reads to the CT18 reference genome (accession AL513382), were used to
assign genotypes for each novel read set using a custom Python script (available at
https://github.com/katholt/genotyphi). Brieﬂy, the script uses samtools mpileup to
extract from each BAM ﬁle the consensus base calls at the SNP loci. The resulting
variant call format ﬁle is then processed to identify the presence of cluster-, clade-
and/or subclade-deﬁning SNP alleles (deﬁned in Supplementary Table 2) that pass
a minimum quality threshold (default consensus base Phred score Z20) and uses
these to assign the read set to a cluster, clade and subclade. Discriminatory power
was calculated using the method outlined in ref. 31.
Data availability. Raw sequence data are available in the European Nucleotide
Archive under accession ERP001718. Supplementary Data 1 lists accession num-
bers for each isolate. The software for Microreact interactive tree viewer is available
at: http://microreact.org/project/styphi22. SMALT is available at: http://
www.sanger.ac.uk/resources/software/smalt/. Python script to visualize and
annotate trees is available at https://github.com/katholt/plotTree/#python-code.
Python script to call SNPs is downloadable at https://github.com/katholt/
genotyphi.
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